Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

NCT05271266 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05271266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05271266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 22, 2022
Completion date
December 6, 2023
Enrollment
1,000 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalaemia